953 related articles for article (PubMed ID: 29869799)
1. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006332. PubMed ID: 29869799
[TBL] [Abstract][Full Text] [Related]
2. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
Candy B; Jones L; Vickerstaff V; Larkin PJ; Stone P
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD006332. PubMed ID: 36106667
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
[TBL] [Abstract][Full Text] [Related]
4. Mu-opioid antagonists for opioid-induced bowel dysfunction.
McNicol ED; Boyce D; Schumann R; Carr DB
Cochrane Database Syst Rev; 2008 Apr; (2):CD006332. PubMed ID: 18425947
[TBL] [Abstract][Full Text] [Related]
5. Laxatives or methylnaltrexone for the management of constipation in palliative care patients.
Candy B; Jones L; Goodman ML; Drake R; Tookman A
Cochrane Database Syst Rev; 2011 Jan; (1):CD003448. PubMed ID: 21249653
[TBL] [Abstract][Full Text] [Related]
6. Methylnaltrexone for opioid-induced constipation in advanced illness.
Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
[TBL] [Abstract][Full Text] [Related]
7. Oxycodone for cancer-related pain.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD003870. PubMed ID: 28829910
[TBL] [Abstract][Full Text] [Related]
8. Oxycodone for cancer-related pain.
Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS; Page AJ; Chi Y
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD003870. PubMed ID: 35679121
[TBL] [Abstract][Full Text] [Related]
9. Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials.
Hale M; Wild J; Reddy J; Yamada T; Arjona Ferreira JC
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):555-564. PubMed ID: 28576452
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.
Mori M; Ji Y; Kumar S; Ashikaga T; Ades S
Int J Clin Oncol; 2017 Apr; 22(2):397-404. PubMed ID: 27628064
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
[TBL] [Abstract][Full Text] [Related]
12. Oxycodone for neuropathic pain in adults.
Gaskell H; Derry S; Stannard C; Moore RA
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010692. PubMed ID: 27465317
[TBL] [Abstract][Full Text] [Related]
13. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
[TBL] [Abstract][Full Text] [Related]
14. Laxatives for the management of constipation in people receiving palliative care.
Candy B; Jones L; Larkin PJ; Vickerstaff V; Tookman A; Stone P
Cochrane Database Syst Rev; 2015 May; 2015(5):CD003448. PubMed ID: 25967924
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
[TBL] [Abstract][Full Text] [Related]
16. Hydromorphone for cancer pain.
Li Y; Ma J; Lu G; Dou Z; Knaggs R; Xia J; Zhao S; Dong S; Yang L
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD011108. PubMed ID: 34350974
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.
Ford AC; Brenner DM; Schoenfeld PS
Am J Gastroenterol; 2013 Oct; 108(10):1566-74; quiz 1575. PubMed ID: 23752879
[TBL] [Abstract][Full Text] [Related]
18. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
Slatkin N; Thomas J; Lipman AG; Wilson G; Boatwright ML; Wellman C; Zhukovsky DS; Stephenson R; Portenoy R; Stambler N; Israel R
J Support Oncol; 2009; 7(1):39-46. PubMed ID: 19278178
[TBL] [Abstract][Full Text] [Related]
19. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
Leppert W
Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
[TBL] [Abstract][Full Text] [Related]
20. Oral tapentadol for cancer pain.
Wiffen PJ; Derry S; Naessens K; Bell RF
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011460. PubMed ID: 26403220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
